Zoetis Inc (NYSE:ZTS). reported its fourth-quarter 2024 earnings, surpassing analysts' expectations with an earnings per share (EPS) of $1.40 compared to the forecasted $1.38. Despite the earnings ...
Agios Pharmaceuticals reported its fourth-quarter 2024 earnings, surpassing analysts' expectations with an earnings per share (EPS) of -$1.44 compared to the forecast of -$1.68. The company also ...